Replies to post #485 on Oramed Pharmaceuticals Inc (ORMP)

[trendmkr]

Oramed presented at a couple of biopharm conferences this month - good exposure for the company

JERUSALEM, Feb. 7, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming BIO CEO & Investor Conference, taking place February 13-14, 2017 in New York City, and the 2017 Disruptive Growth and Healthcare Conference, taking place February 15-16, 2017, also in New York City.